↓ Skip to main content

An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study

Overview of attention for article published in Trials, July 2021
Altmetric Badge

Mentioned by

news
1 news outlet
twitter
4 X users

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
87 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study
Published in
Trials, July 2021
DOI 10.1186/s13063-021-05404-4
Pubmed ID
Authors

Arjune Sen, Mary Akinola, Xin You Tai, Mkael Symmonds, Gabriel Davis Jones, Sergio Mura, Joanne Galloway, Angela Hallam, Jane Y. C. Chan, Ivan Koychev, Chris Butler, John Geddes, Rohan Van Der Putt, Sian Thompson, Sanjay G. Manohar, Eleni Frangou, Sharon Love, Rupert McShane, Masud Husain

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 87 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 11%
Student > Master 10 11%
Student > Bachelor 6 7%
Professor > Associate Professor 4 5%
Other 3 3%
Other 16 18%
Unknown 38 44%
Readers by discipline Count As %
Medicine and Dentistry 18 21%
Neuroscience 11 13%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Nursing and Health Professions 4 5%
Psychology 3 3%
Other 9 10%
Unknown 37 43%